Novo Nordisk Has a Fresh New Name -- but It Still Faces the Same Old Problems
Key PointsNovo Nordisk is in the middle of an important product launch, as it rolls out a pill version of its GLP-1 drug.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.